Institutional & Family Asset Management, LLC Sab Biotherapeutics, Inc. Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$0.38 - $1.09 $16,056 - $46,055	42,253 Added 28.21%	192,027 $159,000
Q3 2022 Nov 07, 2022	BUY	$0.13 - $12.4 $9,315 - $888,571	71,659 Added 91.74%	149,774 $105,000
Q4 2021 Feb 14, 2022	BUY	$7.3 - $11.24 $570,239 - $878,012	78,115 New	78,115 $610,000

Others Institutions Holding SABS

# of Institutions

Shares Held

529K

Call Options Held

Put Options Held

Pathstone Family Office, LLC Englewood, NJ

507K
Shares

$2.02 Million
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

17.5K
Shares

$69,689
0.0% of portfolio
Spectrum Management Group, LLC

5.03K
Shares

$20,069
0.0% of portfolio

View Full List

About SAB Biotherapeutics, Inc.

Ticker SABS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,030,900
Market Cap $172M
Description
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases ...

More about SABS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account